DesiCorp develops a patented process that utilizes ultrasonic waves to infuse protectants into packed red blood cells, enabling their freeze-drying and long-term storage. This technology addresses the challenge of rapid blood transfusion in emergency situations by allowing medics to store and deploy viable blood products for years, ensuring immediate access when needed.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of storing red blood cells (RBCs) require refrigeration and have limited shelf lives, posing logistical challenges for emergency medical care in remote locations or during crises. The need for readily available blood for transfusions in critical situations is unmet due to storage limitations.
Solution
DesiCorp is developing a patented process using ultrasonic waves to infuse protectants into packed RBCs, enabling freeze-drying and long-term storage without compromising cell viability. This technology allows medics and blood technicians to store and deploy viable blood products for extended periods, ensuring immediate access to blood for transfusions when needed. The process significantly extends the shelf life of RBCs, making long-term storage possible and addressing the logistical challenges of maintaining blood supplies in emergency situations.
Target Audience
The primary users are medics, blood technicians, and medical personnel in emergency care settings who require immediate access to viable blood for transfusions.
Features
- Patented ultrasonic process for infusing protectants into RBCs
- Enables freeze-drying of RBCs for long-term storage
- Maintains cell viability throughout the drying and rehydration process
- Allows for rapid blood transfusion in emergency situations